Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease

Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease

US Patent 9505739 · Granted Nov 29, 2016

Estimated economic value: $117,163,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Kinase inhibitors2025
Antiplatelet drugs and uses thereof2025
2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors2025
Pyrrolidine orexin receptor agonists2025
2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors2025
Macrocyclic compounds and methods of use thereof2025
Methods of editing DNA methylation2024
Synthesis methods for upadacitinib and intermediate thereof2024
Antiplatelet drugs and uses thereof2023
Small molecule drug conjugates of gemcitabine monophosphate2023
Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, composi2023
ERK inhibitor and use thereof2022